No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Alvotech/Advanz’s Biosimilar Aflibercept EU Approved
On 21 August 2025, Alvotech and Advanz Pharma announced that Mynzepli® (AVT06), biosimilar to Regeneron/Bayer’s 2mg Eylea® (aflibercept) has been approved by the European Commission in pre-